Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01497561
What this trial is testing

Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 15
Large-scale testing (Phase 3)Study completedNCT00432276
What this trial is testing

Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 803
Large-scale testing (Phase 3)Study completedNCT02856113
What this trial is testing

Phase 3 Alogliptin Pediatric Study

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 152
Testing effectiveness (Phase 2)Study completedNCT00266240
What this trial is testing

GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 267
Testing effectiveness (Phase 2)Study completedNCT01966393
What this trial is testing

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 23
Testing effectiveness (Phase 2)Study completedNCT03848793
What this trial is testing

Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

Who this might be right for
Diabetes Mellitus, Type 2
Jiangsu HengRui Medicine Co., Ltd. 128
Large-scale testing (Phase 3)Study completedNCT01106625
What this trial is testing

The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 469
Testing effectiveness (Phase 2)Study completedNCT01447147
What this trial is testing

Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyType 2 Diabetes Mellitus
Amgen 332
Testing effectiveness (Phase 2)Ended earlyNCT01647308
What this trial is testing

Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Ionis Pharmaceuticals, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01018017
What this trial is testing

A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 86
Early research (Phase 1)Study completedNCT02292433
What this trial is testing

Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT00151749
What this trial is testing

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Daiichi Sankyo 260
Large-scale testing (Phase 3)Study completedNCT03113448
What this trial is testing

0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy

Who this might be right for
Peripheral Diabetic Neuropathy
Thammasat University 42
Post-approval studies (Phase 4)Study completedNCT00690235
What this trial is testing

Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderDiabetes+1 more
University of Texas Southwestern Medical Center 33
Post-approval studies (Phase 4)Study completedNCT02002221
What this trial is testing

Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals 156
Large-scale testing (Phase 3)Ended earlyNCT00261352
What this trial is testing

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,000
Early research (Phase 1)Study completedNCT02064348
What this trial is testing

A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 168
Early research (Phase 1)Study completedNCT02715193
What this trial is testing

Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes MellitusDiabetes
REMD Biotherapeutics, Inc. 21
Testing effectiveness (Phase 2)Study completedNCT03655535
What this trial is testing

Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

Who this might be right for
Type2 Diabetes Mellitus
Boston Therapeutics 66
Large-scale testing (Phase 3)Study completedNCT02947620
What this trial is testing

Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)

Who this might be right for
Type II DiabetesDyslipidemia
Daewoong Pharmaceutical Co. LTD. 185
Next Page